REGN vs SEG · P/E 14, rev $4.29B vs rev $130.4M
Regeneron Pharmaceuticals Inc (REGN) versus Seaport Entertainment Group Inc. (SEG) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Seaport Entertainment Group Inc. (SEG) is a real estate services company listed on NYSE.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SEG revenue for 2025-12-31 was $130.4M. Net income was -$116.7M. Revenue was up 17.3% from 2024-12-31 to 2025-12-31. SEG currently screens at market cap $310.6M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SEG currently screens at market cap $310.6M.
Not investment advice. Open the REGN and SEG stock pages for the full models.
Not investment advice.